NEW YORK (360Dx) — Gregor Diagnostics announced today that it has raised $900,000 in seed funding, which the company will use to further develop its prostate cancer screening test.

The financing was led by First Round and Green Park & Golf Ventures. Other participants include the Wisconsin Alumni Research Foundation, Nat Turner and Zach Weinberg of Flatiron Health, existing investor Health Wildcatters.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.


This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.